Literature DB >> 12004314

Elephantiasic pretibial myxedema: a novel treatment for an uncommon disorder.

Wendy S Susser1, Amanda G Heermans, M Shane Chapman, Richard D Baughman.   

Abstract

Pretibial myxedema is a known manifestation of Graves' disease. Much less common is the elephantiasis nostras variant, which is often refractory to treatment. We therefore elected to try a new therapy, often used for the management of chronic lymphedema, called complete decongestive physiotherapy. After 6 weeks of intensive treatment, our patient lost 37 pounds and had reduced her edema volume by 47%. Her skin softened with decreased lymph seepage and she became mobile for the first time in years. At a 2-year follow-up visit, she exhibited sustained improvement. This case demonstrates that complete decongestive physiotherapy can provide effective, long-term control of this disease process. We suggest that complete decongestive physiotherapy be considered in patients with severe forms of pretibial myxedema, as well as those with refractory lymphedema.

Entities:  

Mesh:

Year:  2002        PMID: 12004314     DOI: 10.1067/mjd.2002.119655

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Elephantiatic dermopathy.

Authors:  Paul Madaj; Laron McPhaul; Andrew G Gianoukakis
Journal:  Int J Dermatol       Date:  2012-03-14       Impact factor: 2.736

Review 2.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

3.  Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Authors:  Ziwei Ren; Min He; Fang Deng; Yan Chen; Liyin Chai; Bing Chen; Wuquan Deng
Journal:  Ther Clin Risk Manag       Date:  2017-09-08       Impact factor: 2.423

4.  Pretibial Myxedema Presenting as Severe Elephantiasis.

Authors:  Jae-Hoon Lee; Sang-Myung Park; Bark-Lynn Lew; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2018-08-28       Impact factor: 1.444

5.  Successful therapeutic approach in a patient with elephantiasic pretibial myxedema.

Authors:  Marina Ferreira; Luciana Helena Zacaron; Annair Freitas do Valle; Aloisio Carlos Couri Gamonal
Journal:  An Bras Dermatol       Date:  2019-11-25       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.